Safety, tolerability, and efficacy of insulin aspart in people with type 2 diabetes, as biphasic insulin aspart or with Basal insulin: findings from the multinational, non-interventional a1chieve study
. . Hajjaji I, Shah S, Li Y, Prusty V, Benabbas Y, Home PD. . Diabetes Ther. 2014 Jun;5(1):113-26. doi: 10.1007/s13300-014-0052-4. Epub 2014 Jan 30. Abstract INTRODUCTION: The aim of the study was to investigate the clinical safety and effectiveness of starting insulin aspart (aspart) therapy in people with type 2 diabetes mellitus (T2DM) as …